Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Dr Reddy’s Laboratories ( (RDY) ) has shared an update.
On July 15, 2025, Dr. Reddy’s Laboratories announced that it will release its Q1FY26 financial results on July 23, 2025, following a Board Meeting. An earnings call is scheduled for the same day at 19:30 PM IST / 10:00 AM ET to discuss the company’s financial performance. The results will be made available through stock exchanges, media, the company’s website, and email, with a press meet presentation and earnings call transcript also accessible online. This announcement is significant as it provides stakeholders with insights into the company’s financial health and strategic direction for the upcoming fiscal year.
The most recent analyst rating on (RDY) stock is a Buy with a $17.40 price target. To see the full list of analyst forecasts on Dr Reddy’s Laboratories stock, see the RDY Stock Forecast page.
Spark’s Take on RDY Stock
According to Spark, TipRanks’ AI Analyst, RDY is a Outperform.
The overall stock score for Dr Reddy’s Laboratories is solid, driven primarily by strong financial performance, indicating robust growth and stable operations. However, technical analysis suggests bearish momentum, and the valuation indicates limited dividend income potential, which slightly dampens the overall score.
To see Spark’s full report on RDY stock, click here.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories Limited is a prominent pharmaceutical company based in Hyderabad, India. It is involved in the production and distribution of a wide range of pharmaceutical products and services, with a focus on generic medications, active pharmaceutical ingredients, and proprietary products. The company is listed on multiple stock exchanges, including the National Stock Exchange of India, BSE Limited, New York Stock Exchange, and NSE IFSC Ltd.
Average Trading Volume: 1,737,661
Technical Sentiment Signal: Strong Buy
Current Market Cap: $12.16B
See more insights into RDY stock on TipRanks’ Stock Analysis page.